Location History:
- Osaka, JA (1976)
- Suita, JP (1981 - 1985)
Company Filing History:
Years Active: 1976-1985
Title: Kazuyoshi Katamoto: Innovator in Antibiotic Separation and Concentration
Introduction
Kazuyoshi Katamoto is a notable inventor based in Suita, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of methods for separating and concentrating antibiotics. With a total of 4 patents to his name, Katamoto's work has had a meaningful impact on antibiotic production processes.
Latest Patents
One of his latest patents is a method for separating cephalosporins. This innovative technique involves the interseparation of desacetyl-cephalosporin C, desacetoxy-cephalosporin C, and cephalosporin C. The process is accomplished by adsorbing these available cephalosporins on activated carbon and effecting a fractional elution with water containing 0 to 20 percent (V/V) of an organic solvent or solvents. Another significant patent is related to a method for concentrating .beta.-lactam antibiotic solutions. This invention focuses on concentrating a dilute aqueous solution of a .beta.-lactam antibiotic, which is susceptible to heat, by using a permeable membrane made of poly(ether/amide) or polybenzimidazolone.
Career Highlights
Kazuyoshi Katamoto is currently associated with Takeda Chemical Industries, Inc., a leading pharmaceutical company. His work at Takeda has allowed him to further his research and development in antibiotic technologies. His innovative approaches have contributed to advancements in the pharmaceutical industry.
Collaborations
Throughout his career, Katamoto has collaborated with esteemed colleagues such as Kiyoshi Nara and Yoshio Nakao. These collaborations have fostered a productive environment for innovation and have led to the successful development of various pharmaceutical methods.
Conclusion
Kazuyoshi Katamoto's contributions to antibiotic separation and concentration highlight his role as a significant inventor in the pharmaceutical field. His innovative methods continue to influence the industry and improve antibiotic production processes.